According to FutureWise analysis, the artificial intelligence in genomics market in 2023 was US$0.71 billion, and is expected to reach US$14.91 billion by 2031 at a CAGR of 46.2%. This remarkable growth trajectory highlights the revolutionary effect of AI on genomic data analysis. It allows researchers to process enormous datasets that would take years to analyze manually in just hours or days. Machine learning algorithms are accelerating drug discovery, identifying genetic diseases, and advancing personalized medicine by uncovering complex patterns in DNA sequences and genetic variations.
FutureWise Market Research has released a report that provides an in-depth analysis of Artificial Intelligence in Genomics Market trends that will impact the overall market growth. Furthermore, it includes detailed information on the profitability graph, SWOT analysis, market share, and regional expansion of this business. Moreover, the report offers insights into the current stature of prominent market players in the competitive landscape analysis of this market.
According to a research study conducted by FutureWise research analysts, the Artificial Intelligence in Genomics Market is expected to achieve substantial growth by the end of the forecast period. The report predicts that this business is expected to register a notable growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.